Bristol-Myers Initiates Blood Thinner Recall

Bristol-Myers Initiates Blood Thinner Recall

Posted By Golomb & Honik || 2-Jul-2014

According to the US Food and Drug Administration (FDA), Bristol-Myers Squibb Co has initiated a voluntary recall of their blood thinner, Coumadin. The pharmaceutical company decided to recall six lots of the injectable version of this blood thinner after finding particulate matter in some unreleased samples.

Bristol-Myers called the recall a “precautionary measure” and claimed there have been no drug injuries reported in association with this drug. The recall was initiated after investigators detected some contaminated 5 mg single-use vials.

No Coumadin tablets were included in the recall, which only coves lots of the injectable form distributed in the United States between November 2011 and January 2014.

If you have suffered an injury from taking one of the recalled lots of Coumadin, you may be entitled to recover compensation for your damages. The pharmaceutical injury attorneys at Golomb & Honik have decades of trial experience and have handled numerous drug injury cases. We have the skills to battle the high-powered legal teams employed by pharmaceutical companies. This will give you the edge you need when seeking to maximize the value of your compensation.

Please contact Golomb & Honik today to schedule your free drug injury consultation. We serve clients nationwide from our offices in Philadelphia, Pennsylvania.

Categories: Dangerous Drugs
Blog Home